Direct, Cost-Effective COVID-19 Tests Identify UK/South African SARS-CoV-2 Variant and Reduces Test Time from Days to Hours
|
By LabMedica International staff writers Posted on 19 Mar 2021 |

Illustration
Scientists have developed direct rapid cost-effective COVID-19 tests that successfully identify the UK or South African variant of the SARS-CoV-2 virus.
The tests developed by scientists at the Ben-Gurion University of the Negev (Be'er Sheva, Israel) reduce the time needed to determine whether an infection is caused by a variant from days to hours. Comparatively, current tests for the UK and South African coronavirus variants are either expensive, time-consuming, or indirect. The current standard for coronavirus variants testing is sequencing the entire virus genome, which is expensive and time-consuming.
The new recently-developed RT-qPCR rapid tests are based on the gene deletion that differentiates the variants from the original SARS-CoV-2 strain. The scientists held trials of their tests on sewage samples from Beer-Sheva and successfully detected the UK variant but not the South African variant, which corresponded to the variants prevalent in Israel at the time.
"My lab has been working hard throughout this pandemic to provide early warning and detection tools. Our detection system of corona in wastewater successfully completed a pilot program in 14 cities around Israel," said Prof. Ariel Kushmaro who supervised the development of the tests. "We continue to refine our research in service to humankind."
Related Links:
Ben-Gurion University of the Negev
The tests developed by scientists at the Ben-Gurion University of the Negev (Be'er Sheva, Israel) reduce the time needed to determine whether an infection is caused by a variant from days to hours. Comparatively, current tests for the UK and South African coronavirus variants are either expensive, time-consuming, or indirect. The current standard for coronavirus variants testing is sequencing the entire virus genome, which is expensive and time-consuming.
The new recently-developed RT-qPCR rapid tests are based on the gene deletion that differentiates the variants from the original SARS-CoV-2 strain. The scientists held trials of their tests on sewage samples from Beer-Sheva and successfully detected the UK variant but not the South African variant, which corresponded to the variants prevalent in Israel at the time.
"My lab has been working hard throughout this pandemic to provide early warning and detection tools. Our detection system of corona in wastewater successfully completed a pilot program in 14 cities around Israel," said Prof. Ariel Kushmaro who supervised the development of the tests. "We continue to refine our research in service to humankind."
Related Links:
Ben-Gurion University of the Negev
Latest COVID-19 News
- New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases
- Long COVID Etiologies Found in Acute Infection Blood Samples
- Novel Device Detects COVID-19 Antibodies in Five Minutes
- CRISPR-Powered COVID-19 Test Detects SARS-CoV-2 in 30 Minutes Using Gene Scissors
- Gut Microbiome Dysbiosis Linked to COVID-19
- Novel SARS CoV-2 Rapid Antigen Test Validated for Diagnostic Accuracy
- New COVID + Flu + R.S.V. Test to Help Prepare for `Tripledemic`
- AI Takes Guesswork Out Of Lateral Flow Testing
- Fastest Ever SARS-CoV-2 Antigen Test Designed for Non-Invasive COVID-19 Testing in Any Setting
- Rapid Antigen Tests Detect Omicron, Delta SARS-CoV-2 Variants
- Health Care Professionals Showed Increased Interest in POC Technologies During Pandemic, Finds Study
- Set Up Reserve Lab Capacity Now for Faster Response to Next Pandemic, Say Researchers
- Blood Test Performed During Initial Infection Predicts Long COVID Risk
- Low-Cost COVID-19 Testing Platform Combines Sensitivity of PCR and Speed of Antigen Tests
- Finger-Prick Blood Test Identifies Immunity to COVID-19
- Quick Test Kit Determines Immunity Against COVID-19 and Its Variants
Channels
Clinical Chemistry
view channel
VOCs Show Promise for Early Multi-Cancer Detection
Early cancer detection is critical to improving survival rates, but most current screening methods focus on individual cancer types and often involve invasive procedures. This makes it difficult to identify... Read more
Portable Raman Spectroscopy Offers Cost-Effective Kidney Disease Diagnosis at POC
Kidney disease is typically diagnosed through blood or urine tests, often when patients present with symptoms such as blood in urine, shortness of breath, or weight loss. While these tests are common,... Read moreMolecular Diagnostics
view channel
Fast Low-Cost Alzheimer’s Tests Could Detect Disease in Early and Silent Stages
Early diagnosis remains one of the greatest challenges in combating Alzheimer’s disease, the most common cause of age-related dementia. With symptoms like memory loss and confusion typically appearing... Read more
Further Investigation of FISH-Negative Tests for Renal Cell Carcinoma Improves Diagnostic Accuracy
Accurate diagnosis of renal cell carcinoma (RCC) is critical to determining the right therapy, but standard diagnostic methods can sometimes miss important genetic alterations. Now, researchers have discovered... Read more
First Direct Measurement of Dementia-Linked Proteins to Enable Early Alzheimer’s Detection
The disease process in Alzheimer’s begins long before memory loss or cognitive decline becomes apparent. During this silent phase, misfolded proteins gradually form amyloid fibrils, which accumulate in... Read moreHematology
view channel
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more
Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage
Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more
Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read moreImmunology
view channel
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read more
Blood-Based Liquid Biopsy Model Analyzes Immunotherapy Effectiveness
Immunotherapy has revolutionized cancer care by harnessing the immune system to fight tumors, yet predicting who will benefit remains a major challenge. Many patients undergo costly and taxing treatment... Read moreMicrobiology
view channel
High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample
Gastrointestinal (GI) infections are among the most common causes of illness worldwide, leading to over 1.7 million deaths annually and placing a heavy burden on healthcare systems. Conventional diagnostic... Read more
Fast Noninvasive Bedside Test Uses Sugar Fingerprint to Detect Fungal Infections
Candida bloodstream infections are a growing global health threat, causing an estimated 6 million cases and 3.8 million deaths annually. Hospitals are particularly vulnerable, as weakened patients after... Read morePathology
view channel
3D Genome Mapping Tool to Improve Diagnosis and Treatment of Genetic Diseases
Standard laboratory tests often fail to detect complex DNA rearrangements that underlie many genetic diseases. To bridge this diagnostic gap, researchers have developed a 3D chromosome mapping method that... Read more
New Molecular Analysis Tool to Improve Disease Diagnosis
Accurately distinguishing between similar biomolecules such as proteins is vital for biomedical research and diagnostics, yet existing analytical tools often fail to detect subtle structural or compositional... Read more
Tears Offer Noninvasive Alternative for Diagnosing Neurodegenerative Diseases
Diagnosing and monitoring eye and neurodegenerative diseases often requires invasive procedures to access ocular fluids. Ocular fluids like aqueous humor and vitreous humor contain valuable molecular information... Read moreTechnology
view channel
Portable Biosensor Diagnoses Psychiatric Disorders Using Saliva Samples
Early diagnosis of psychiatric disorders such as depression, schizophrenia, and bipolar disorder remains one of medicine’s most pressing challenges. Current diagnostic methods rely heavily on clinical... Read more
Cell-Sorting Device Uses Electromagnetic Levitation to Precisely Direct Cell Movement
Sorting different cell types—such as cancerous versus healthy or live versus dead cells—is a critical task in biology and medicine. However, conventional methods often require labeling, chemical exposure,... Read moreIndustry
view channel
Qiagen Acquires Single-Cell Omics Firm Parse Biosciences
QIAGEN (Venlo, Netherlands) has entered into a definitive agreement to fully acquire Parse Biosciences (Seattle, WA, USA), a provider of scalable, instrument-free solutions for single-cell research.... Read more
Puritan Medical Products Showcasing Innovation at AMP2025 in Boston
Puritan Medical Products (Guilford, ME, USA), the world’s most trusted manufacturer of swabs and specimen collection devices, is set to exhibit at AMP2025 in Boston, Massachusetts, from November 11–15.... Read more
Advanced Instruments Merged Under Nova Biomedical Name
Advanced Instruments (Norwood, MA, USA) and Nova Biomedical (Waltham, MA, USA) are now officially doing business under a single, unified brand. This transformation is expected to deliver greater value... Read more









